PPH.US VanEck Pharmaceutical ETF

- USD
No recent price
Total assets
1.08B
Expense ratio
0.36%
Dividend yield
1.79%
1-year return
+24.47%
Holdings
25
Since
2011

Fund data as reported by the issuer, updated Nov 17, 2026. Total assets are in the fund's base currency.

What does PPH.US invest in?

  • Mostly US stocks (71.6%)
  • Largest sector: Healthcare (96.9%)
  • Largest region: North America (71.6%)
  • Top 3 holdings: 40.6% of the fund

Asset allocation

  • US stocks 71.6%
  • Non-US stocks 29.9%
  • Cash 0.0%

Top holdings

All holdings, sectors and regions

VanEck Pharmaceutical ETF performance

Sharpe ratio 1.00
This year
+19.41%
1 year
+24.47%
3 years
+19.94%
5 years
+11.75%

Volatility 17.0% over 1 year and 14.2% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

PPH.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About VanEck Pharmaceutical ETF

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Full fund profile